Accepted: 10 June 2021
First Online: 20 July 2021
: J.J. has acted as a consultant of and received research support from Artios Pharma. S.G. has acted as a consultant of Foghorn Therapeutics, Foundation Medicine, Inspirata, Merck, Novartis, and Roche and has received research funding from M2Gen; his spouse is an employee of Merck and holds equity in Merck. The other authors declare no competing interests.